Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Short term Debt (2020 - 2021)

Oncology Institute (TOI) has disclosed Short term Debt for 2 consecutive years, with $183000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Short term Debt fell 96.59% year-over-year to $183000.0, compared with a TTM value of $183000.0 through Dec 2021, down 96.59%, and an annual FY2021 reading of $183000.0, down 96.59% over the prior year.
  • Short term Debt was $183000.0 for Q4 2021 at Oncology Institute, down from $5.4 million in the prior quarter.
  • Across five years, Short term Debt topped out at $5.4 million in Q4 2020 and bottomed at $183000.0 in Q4 2021.